본문 바로가기
KERD
논문KCI 등재

Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)

김일환|안지영|김진주|김병수|정기현|박해진|김광중|고주연|손상욱|이은소|김동현|이운하|Javed Rashid
대한피부과학회 (Korean Dermalogical Association)|2023.04|Annals of Dermatology|제35권 제2호|pp. 107-115|DOI https://doi.org/10.5021/ad.22.041

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Health-related quality of lifePsoriasisAdalimumab
주제분류피부과학

초록

Background: Psoriasis imposes a significant treatment burden on patients, particularly impacting well-being and quality of life (QoL). The psychosocial impact of psoriasis treatments remains unexplored in most patient populations

Abstract

Background: Psoriasis imposes a significant treatment burden on patients, particularly impacting well-being and quality of life (QoL). The psychosocial impact of psoriasis treatments remains unexplored in most patient populations

참고문헌 (29)

  1. Hugh JM, "Update on the pathophysiology of psoriasis", Cutis, 102(5S), pp.6~12 (2018)
  2. AlQassimi S, "Global burden of psoriasis-comparison of regional and global epidemiology, 1990to 2017", Int J Dermatol, 59, pp.566~571 (2020)
  3. Mehrmal S, "The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017 : a systematic analysis from the Global Burden of Disease Study 2017", J Am Acad Dermatol, 84, pp.46~52 (2021)
  4. Peng C, "Epidemiological variations in the global burden of psoriasis, an analysis with trends from 1990 to 2017", Front Med(Lausanne), 8, pp.585634~ (2021)
  5. "Global Report on Psoriasis" (2016)[URL]
  6. Bhosle MJ, "Quality of life in patients with psoriasis", Health Qual Life Outcomes, 4, pp.35~ (2006)
  7. Kim WB, "Diagnosis and management of psoriasis", Can Fam Physician, 63, pp.278~285 (2017)
  8. Strober B, "Recategorization of psoriasis severity : Delphi consensus from the International Psoriasis Council", J Am Acad Dermatol, 82, pp.117~122 (2020)
  9. Callen JP, "AAD consensus statement on psoriasis therapies", J Am Acad Dermatol, 49, pp.897~899 (2003)
  10. Wolf P, "Quality of life and treatment goals in psoriasis from the patient perspective : results of an Austrian cross-sectional survey", J Dtsch Dermatol Ges, 16, pp.981~990 (2018)
  11. 이진용, "Prevalence of Psoriasis in Korea: A Population-Based Epidemiological Study Using the Korean National Health Insurance Database", Annals of Dermatology, 29(6), pp.761~767 (2017), 대한피부과학회
  12. Croom KF, "Adalimumab : in plaque psoriasis", Am J Clin Dermatol, 10, pp.43~50 (2009)
  13. Reich K, "Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-tosevere plaque psoriasis", Dermatology, 219, pp.239~249 (2009)
  14. Revicki D, "Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes : results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis", Br J Dermatol, 158, pp.549~557 (2008)
  15. Revicki DA, "Impact of adalimumab treatment on patientreported outcomes : results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis", J Dermatolog Treat, 18, pp.341~350 (2007)
  16. Leman J, "The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis : a UK prospective, multicenter, observational study", J Dermatolog Treat, 31, pp.213~221 (2020)
  17. de Arruda LH, "The impact of psoriasis on quality of life", Br J Dermatol, 144(Suppl 58), pp.33~36 (2001)
  18. Kurd SK, "The risk of depression, anxiety, and suicidality in patients with psoriasis : a population-based cohort study", Arch Dermatol, 146, pp.891~895 (2010)
  19. Ghajarzadeh M, "Associations between skin diseases and quality of life : a comparison of psoriasis, vitiligo, and alopecia areata", Acta Med Iran, 50, pp.511~515 (2012)
  20. Karelson M, "Quality of life and emotional state in vitiligo in an Estonian sample : comparison with psoriasis and healthy controls", Acta Derm Venereol, 93, pp.446~450 (2013)
  21. Gupta MA, "Psychiatric and psychological co-morbidity in patients with dermatologic disorders : epidemiology and management", Am J Clin Dermatol, 4, pp.833~842 (2003)
  22. Patel N, "Psoriasis, depression, and inflammatory overlap : a review", Am J Clin Dermatol, 18, pp.613~620 (2017)
  23. Picardi A, "Suicide risk in skin disorders", Clin Dermatol, 31, pp.47~56 (2013)
  24. Anstey A, "Extending psychosocial assessment of patients with psoriasis in the UK, using a selfrateds, web-based survey", Clin Exp Dermatol, 37, pp.735~740 (2012)
  25. Connor CJ, "Exploring the physiological link between psoriasis and mood disorders", Dermatol Res Pract, 2015, pp.409637~ (2015)
  26. Fortune DG, "Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being", Br J Dermatol, 151, pp.1219~1226 (2004)
  27. de Korte J, "Quality of life in patients with psoriasis : a systematic literature review", J Investig Dermatol Symp Proc, 9, pp.140~147 (2004)
  28. Burgos-Pol R, "The cost of psoriasis and psoriatic arthritis in 5 European countries : a systematic review", Actas Dermosifiliogr, 107, pp.577~590 (2016)
  29. Prignano F, "A global approach to psoriatic patients through PASI score and Skindex-29", G Ital Dermatol Venereol, 146, pp.47~52 (2011)

관련 논문AI추천

Secukinumab Response in Korean Patients with Moderate to Severe Plaque-Type Psoriasis Irrespective of Previous Biologic Use: 1-Year Experience at a Single Center권수현, 이은소대한피부과학회 · Annals of Dermatology2020 · 제32권 제3호Real-World Experience with Etanercept Therapy and the Switching Pattern among Korean Patients with Psoriasis after Withdrawal of Etanercept김보리, 유다애, 윤상웅, 이지수, 최종원대한피부과학회 · Annals of Dermatology2019 · 제31권 제1호Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea고현창, 나찬호, 노주영, 박귀영, 박영립, 박영민, 박창욱, 박천욱, 배유인, 서영준, 손상욱, 안지영, 양준모, 원종현, 유광호, 유박린, 이동훈, 이상은, 이성열, 이승철, 이양원, 이지현, 장용현, 전지현, 정혜정, 조상현, 한태영대한피부과학회 · Annals of Dermatology2022 · 제34권 제2호Comparison of Treatment Goals for Moderate-to-Severe Psoriasis between Korean Dermatologists and the European Consensus Report김광중, 김낙인, 김보리, 송해준, 윤상웅, 윤재일, 이주흥, 최용범, 최지호대한피부과학회 · Annals of Dermatology2015 · 제27권 제2호The MARCOPOLO Study of Ustekinumab Utilization and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries윤상웅, 이민걸, Antonio Pires, Benny E. Wiryadi, Colin Theng, Siew-Eng Choon, Tsen-Fang Tsai, Weihao Tan대한피부과학회 · Annals of Dermatology2016 · 제28권 제2호Differences in Clinical Responses to Ustekinumab Treatment among Body Regions: Results from a Real-World Prospective, Observational, and Multi-Center Study in Korea김명화, 김영도, 노주영, 박경훈, 손상욱, 안효현, 유대영, 윤상웅, 윤현선, 이영복, 이영자, 이지연, 장용현대한피부과학회 · Annals of Dermatology2022 · 제34권 제1호

이 간행물의 다른 논문 (13건)

Greetings from the New Editor-in-Chief조소연pp. 89-90The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant RecipientsCatherine Zilberg, James Guy Lyons, Ruta Gupta, Angela Ferguson, DionaL.Damianpp. 91-99Various Applications of Purse-String Suture and Its Cosmetic Outcome in Cutaneous Surgical Defects노미령, 이종원, 오영주, 최수이, 정기양, 남경애, 박수진pp. 100-106Pitavastatin Induces Apoptosis of Cutaneous Squamous Cell Carcinoma Cells through Geranylgeranyl PyrophosphateDependent c-Jun N-Terminal Kinase Activatio김경일, 이영, 김승미, 윤태진, 이영윤, 김창덕pp. 116-123Prescription Patterns of Topical Medications in Patients with Atopic Dermatitis: An Investigative Review Using Big Data from the National Health Insurance Corporation김문범, 김진미, 김병수, 김태영, 이정수, 고현창, 김훈수, 천상진pp. 124-131
원문 보기